Linked Life Data

20880779

Source:http://linkedlifedata.com/resource/pubmed/id/20880779

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2010-9-30
pubmed:abstractText
Diffusion-weighted magnetic resonance imaging (DWI) is increasingly being used to assess tumour response to a variety of anticancer treatments. The technique is quick to perform without the need for administration of exogenous contrast medium, and enables the apparent diffusion coefficient (ADC) of tissues to be quantified. Studies have shown that ADC increases in response to a variety of treatments including chemotherapy, radiotherapy, minimally invasive therapies and novel therapeutics. In this article, we review the rationale of applying DWI for tumour assessment, the evidence for ADC measurements in relation to specific treatments and some of the practical considerations for using ADC to evaluate treatment response.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
1470-7330
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
10 Spec no A
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S179-88
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?
pubmed:affiliation
Royal Marsden Hospital, Downs Road, Sutton, UK.
pubmed:publicationType
Journal Article, Review